Merck upgraded to Overweight at Morgan Stanley, target raised to $179
Merck (MRK) is upgraded to Overweight from Equal Weight at Morgan Stanley, which also raises its price target to $179 from $116.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.